RELX

RELX PLC provides analytics and decision tools for professional customers globally. The company operates four segments: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. The Risk segment offers risk evaluation and prediction tools combining public content with technology. The Scientific, Technical & Medical segment provides information and data sets for researchers and healthcare professionals. The Legal segment offers legal, regulatory, and business information and analytics for decision-making. The Exhibitions segment combines face-to-face events with digital tools for market learning and transactions. The company was previously known as Reed Elsevier PLC before changing its name to RELX PLC in 2015.

Overview

Sector

Business Services

Target Price

24.5 EUR

Current Price

30.4 EUR

Potential

-19%

Strengths

Earnings are projected to grow at a solid rate (10.7% per year).
The company has high returns. ROIC (29.74%) is higher than the sector mean (14.24%).
Price to free cash flow (20.18) is lower than the sector mean.
Strong EBITDA Margin of 38.63%.

Weaknesses

With a depreciation Potential of -18.17%, based on our fundamental analysis, it suggests the stock may be overvalued.
Price to book ratio (19.72) is significantly higher than the sector mean (10.34).

Indicator	Value
PER	23.0
EV/EBITDA	14.7
Price/Free Cash Flow'	20.5
ROIC	29.7%
Net Debt/EBITDA	1.9

RELX

Overview

Strengths

Weaknesses

Key Financial Data